AbbVie | ABBV - Equity Capital And Reserves

Stock Price
217.23
Daily Change
-8.43 -3.74%
Monthly
-1.34%
Yearly
13.29%
Q1 Forecast
216.14

AbbVie reported $-2.64B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -2.64B 2.46B Sep/2025
Abbott USD 50.83B 0 Sep/2025
ALKERMES USD 1.73B 108.85M Sep/2025
Amgen USD 9.62B 2.19B Sep/2025
AstraZeneca USD 45.89B 1.17B Sep/2025
Biogen USD 18.21B 573.5M Sep/2025
BioMarin Pharmaceutical USD 6.06B 29.6M Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Eisai JPY 854.43B 25.92B Sep/2025
Eli Lilly USD 23.79B 5.52B Sep/2025
Gilead Sciences USD 21.46B 1.78B Sep/2025
GlaxoSmithKline GBP 16.15B 1.79B Sep/2025
J&J USD 78.47B 0 Sep/2025
Medtronic USD 47.89B 131M Jun/2025
Merck USD 51.85B 2.79B Sep/2025
Neurocrine Biosciences USD 3B 309.3M Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Pacira USD 727.21M 30.55M Sep/2025
Perrigo USD 4.45B 25.8M Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Regeneron Pharmaceuticals USD 31.26B 299.1M Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 71.71B 1.55B Dec/2025
UCB EUR 10.03B 1.08B Dec/2024
Ultragenyx Pharmaceutical USD 9.16M 142.13M Sep/2025
United Therapeutics USD 6.59B 583.4M Sep/2025
Vertex Pharmaceuticals USD 17.32B 143.4M Sep/2025
Zoetis USD 5.4B 421M Sep/2025